Skip to Main Content

Faculty Directory

Back to
Faculty Directory
Adeel Khan, M.D.

Adeel Khan, M.D.

Titles and Appointments

Director of Myeloma Epidemiology Research | Clinical Director of Monoclonal Gammopathy Precursor Clinic

Assistant Professor

School
Medical School
Department
Internal Medicine | Public Health

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Adeel Khan, M.D., M.P.H., M.S., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He is also an Assistant Professor in the Peter O’Donnell Jr. School of Public Health. He specializes in myeloma, amyloidosis, and Waldenström macroglobulinemia and serves as the Director of Myeloma Epidemiology Research and Clinical Director of the Monoclonal Gammopathy Precursor Clinic.

    Dr. Khan earned his medical degree with special distinction at the University of Michigan in Ann Arbor, Michigan, while also obtaining a master’s degree in public health from Harvard University. He performed a residency in internal medicine at the Cleveland Clinic and Lerner College of Medicine in Cleveland, Ohio. After serving as a hospitalist at Massachusetts General Hospital and an instructor at Harvard Medical School and concurrently obtaining a master's degree in epidemiology from Columbia University, he gained advanced training in hematology and oncology through a fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School.

    Board certified in internal medicine and hematology, he joined the UT Southwestern faculty in 2022.

    Dr. Khan’s research interests include myeloma and other monoclonal gammopathies, as well as cancer epidemiology. He has delivered numerous presentations at large national conferences and published peer-reviewed articles related to his areas of expertise.

    He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, and the American Public Health Association.

  • Education
    Graduate School
    Harvard T.H. Chan School of Public Health (2013), Quantitative Methods
    Medical School
    University of Michigan Medical School (2014)
    Residency
    Cleveland Clinic Foundation (2017), Internal Medicine
    Graduate School
    Columbia University Mailman School of Public Health (2019), Epidemiology
    Fellowship
    Beth Israel Deaconess Medical Center (2022), Hematology Oncology
  • Research Interest
    • Cancer epidemiology
    • Monoclonal gammopathies
    • Multiple myeloma
  • Publications

    Star Featured Publications

    Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis.
    Hoff FW, Banerjee R, Khan AM, McCaughan G, Wang B, Wang X, Roose J, Anderson LD, Cowan AJ, Rajkumar SV, Kaur G, Blood Cancer J 2024 Mar 14 1 52
    Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study.
    Khan AM, Chiasakul T, Redd R, Patell R, McCarthy EP, Neuberg D, Zwicker JI, PLoS Med 2022 May 19 5 e1004012
    A Cancer by Any Other Name.
    Khan AM, Oncologist 2021 Jul
    Facing inadequacies: cultivating compassion from past failures.
    Khan AM, Lancet Oncol 2021 06 22 6 762-763
    Concerning trends in colorectal cancer in the wake of Chadwick Boseman's death.
    Khan AM, Mucci LA, J Cancer Policy 2020 Dec 26 100260
    Heparin induced thrombocytopenia antibodies in Covid-19.
    Patell R, Khan AM, Bogue T, Merrill M, Koshy A, Bindal P, Joyce R, Aird WC, Neuberg D, Bauer KA, Zwicker JI, Am J Hematol 2020 Oct 95 10 E295-E296
    Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
    Sehgal K, Piper-Vallillo AJ, Viray H, Khan AM, Rangachari D, Costa DB, Precis Cancer Med 2020 Jun 3
  • Honors & Awards
    • Excellence in Teaching Award
      Cleveland Clinic (2017)
    • James H. Ware Award for Achievement in the Practice of Public Health
      Harvard University (2013)
    • Trong D. Nguyen Memorial Award
      American Public Health Association (2013)
    • Making a Difference Award
      University of Michigan (2011)
  • Professional Associations/Affiliations
    • American College of Physicians
    • American Public Health Association
    • American Society of Clinical Oncology
    • American Society of Hematology